Any 0 3 0 3 O
ocular 4 10 4 10 B-treatment
surgery 11 18 11 18 I-treatment
( 19 20 19 20 O
including 20 29 20 29 O
cataract 30 38 30 38 B-treatment
extraction 39 49 39 49 I-treatment
or 50 52 50 52 O
capsulotomy 53 64 53 64 B-treatment
) 64 65 64 65 O
of 66 68 66 68 O
the 69 72 69 72 O
study 73 78 73 78 O
eye 79 82 79 82 O
anticipated 83 94 83 94 O
within 95 101 95 101 O
the 102 105 102 105 O
first 106 111 106 111 O
180 112 115 112 115 B-upper_bound
days 116 120 116 120 I-upper_bound
following 121 130 121 130 O
Day 131 134 131 134 O
0 135 136 135 136 O

Any 0 3 137 140 O
significant 4 15 141 152 O
ocular 16 22 153 159 B-chronic_disease
disease 23 30 160 167 I-chronic_disease
that 31 35 168 172 O
could 36 41 173 178 O
compromise 42 52 179 189 O
the 53 56 190 193 O
visual 57 63 194 200 O
outcome 64 71 201 208 O
in 72 74 209 211 O
the 75 78 212 215 O
study 79 84 216 221 O
eye 85 88 222 225 O

Best 0 4 226 230 O
- 4 5 230 231 O
corrected 5 14 231 240 O
ETDRS 15 20 241 246 B-clinical_variable
visual 21 27 247 253 I-clinical_variable
acuity 28 34 254 260 I-clinical_variable
of 35 37 261 263 O
20/400 38 44 264 270 B-lower_bound
or 45 47 271 273 O
better 48 54 274 280 O
( 55 56 281 282 O
approximately 56 69 282 295 O
20 70 72 296 298 O
letters 73 80 299 306 O
) 80 81 306 307 O
in 82 84 308 310 O
the 85 88 311 314 O
study 89 94 315 320 O
eye 95 98 321 324 O

Best 0 4 325 329 B-clinical_variable
- 4 5 329 330 I-clinical_variable
corrected 5 14 330 339 I-clinical_variable
ETDRS 15 20 340 345 I-clinical_variable
visual 21 27 346 352 I-clinical_variable
acuity 28 34 353 359 I-clinical_variable
of 35 37 360 362 O
20/400 38 44 363 369 B-lower_bound
or 45 47 370 372 O
better 48 54 373 379 O
in 55 57 380 382 O
the 58 61 383 386 O
fellow 62 68 387 393 O
eye 69 72 394 397 O
( 73 74 398 399 O
approximately 74 87 399 412 O
20 88 90 413 415 O
letters 91 98 416 423 O
) 98 99 423 424 O

Capsulotomy 0 11 425 436 B-treatment
within 12 18 437 443 O
30 19 21 444 446 B-upper_bound
days 22 26 447 451 I-upper_bound
prior 27 32 452 457 I-upper_bound
to 33 35 458 460 O
Day 36 39 461 464 O
0 40 41 465 466 O
in 42 44 467 469 O
the 45 48 470 473 O
study 49 54 474 479 O
eye 55 58 480 483 O

Have 0 4 484 488 O
active 5 11 489 495 O
uveitis 12 19 496 503 B-chronic_disease
, 19 20 503 504 O
defined 21 28 505 512 O
as 29 31 513 515 O
having 32 38 516 522 O
at 39 41 523 525 O
least 42 47 526 531 O
1 48 49 532 533 B-lower_bound
+ 49 50 533 534 O
Vitreous 51 59 535 543 B-clinical_variable
Haze 60 64 544 548 I-clinical_variable
and/or 65 71 549 555 O
at 72 74 556 558 O
least 75 80 559 564 O
1 81 82 565 566 O
+ 82 83 566 567 O
Vitreous 84 92 568 576 B-clinical_variable
Cell 93 97 577 581 I-clinical_variable
Count 98 103 582 587 I-clinical_variable
( 104 105 588 589 O
SUN 105 108 589 592 O
scale 109 114 593 598 O
) 114 115 598 599 O

Have 0 4 600 604 O
diagnosis 5 14 605 614 O
of 15 17 615 617 O
uveitis 18 25 618 625 B-chronic_disease
determined 26 36 626 636 O
by 37 39 637 639 O
the 40 43 640 643 O
Investigator 44 56 644 656 O
to 57 59 657 659 O
be 60 62 660 662 O
non 63 66 663 666 O
- 66 67 666 667 O
infectious 67 77 667 677 O
based 78 83 678 683 O
on 84 86 684 686 O
the 87 90 687 690 O
patient 91 98 691 698 O
's 98 100 698 700 O
medical 101 108 701 708 O
history 109 116 709 716 O
, 116 117 716 717 O
history 118 125 718 725 O
of 126 128 726 728 O
present 129 136 729 736 O
illness 137 144 737 744 O
, 144 145 744 745 O
ocular 146 152 746 752 O
examination 153 164 753 764 O
, 164 165 764 765 O
review 166 172 766 772 O
of 173 175 773 775 O
systems 176 183 776 783 O
, 183 184 783 784 O
physical 185 193 785 793 O
examination 194 205 794 805 O
, 205 206 805 806 O
and 207 210 807 810 O
any 211 214 811 814 O
pertinent 215 224 815 824 O
laboratory 225 235 825 835 O
evaluations 236 247 836 847 O

Have 0 4 848 852 O
inactive 5 13 853 861 O
disease 14 21 862 869 O
, 21 22 869 870 O
defined 23 30 871 878 O
as 31 33 879 881 O
having 34 40 882 888 O
0.5 41 44 889 892 B-upper_bound
+ 44 45 892 893 I-upper_bound
Vitreous 46 54 894 902 B-clinical_variable
Haze 55 59 903 907 I-clinical_variable
or 60 62 908 910 O
less 63 67 911 915 O
and 68 71 916 919 O
0.5 72 75 920 923 O
+ 75 76 923 924 O
or 77 79 925 927 O
less 80 84 928 932 O
Vitreous 85 93 933 941 B-clinical_variable
Cell 94 98 942 946 I-clinical_variable
Count 99 104 947 952 I-clinical_variable
( 105 106 953 954 I-clinical_variable
SUN 106 109 954 957 I-clinical_variable
scale 110 115 958 963 I-clinical_variable
) 115 116 963 964 I-clinical_variable

History 0 7 965 972 O
of 8 10 973 975 O
herpetic 11 19 976 984 B-chronic_disease
infection 20 29 985 994 I-chronic_disease
in 30 32 995 997 O
the 33 36 998 1001 O
study 37 42 1002 1007 O
eye 43 46 1008 1011 O
or 47 49 1012 1014 O
adnexa 50 56 1015 1021 O

History 0 7 1022 1029 O
of 8 10 1030 1032 O
vitreoretinal 11 24 1033 1046 B-treatment
surgery 25 32 1047 1054 I-treatment
or 33 35 1055 1057 O
scleral 36 43 1058 1065 B-treatment
buckling 44 52 1066 1074 I-treatment
within 53 59 1075 1081 O
90 60 62 1082 1084 B-upper_bound
days 63 67 1085 1089 I-upper_bound
prior 68 73 1090 1095 I-upper_bound
to 74 76 1096 1098 O
Day 77 80 1099 1102 O
0 81 82 1103 1104 O
in 83 85 1105 1107 O
the 86 89 1108 1111 O
study 90 95 1112 1117 O
eye 96 99 1118 1121 O

Intraocular 0 11 1122 1133 B-clinical_variable
pressure 12 20 1134 1142 I-clinical_variable
≥25 21 24 1143 1146 O
mmHg 25 29 1147 1151 O
in 30 32 1152 1154 O
the 33 36 1155 1158 O
study 37 42 1159 1164 O
eye 43 46 1165 1168 O
( 47 48 1169 1170 O
glaucoma 48 56 1170 1178 B-chronic_disease
patients 57 65 1179 1187 O
maintained 66 76 1188 1198 O
on 77 79 1199 1201 O
no 80 82 1202 1204 O
more 83 87 1205 1209 O
than 88 92 1210 1214 O
2 93 94 1215 1216 O
topical 95 102 1217 1224 B-treatment
medications 103 114 1225 1236 I-treatment
with 115 119 1237 1241 O
IOP 120 123 1242 1245 B-clinical_variable
< 124 125 1246 1247 O
25 125 127 1247 1249 O
mmHg 128 132 1250 1254 O
are 133 136 1255 1258 O
allowed 137 144 1259 1266 O
to 145 147 1267 1269 O
participate 148 159 1270 1281 O
) 159 160 1281 1282 O

Intraocular 0 11 1283 1294 B-treatment
surgery 12 19 1295 1302 I-treatment
within 20 26 1303 1309 O
90 27 29 1310 1312 B-upper_bound
days 30 34 1313 1317 I-upper_bound
prior 35 40 1318 1323 I-upper_bound
to 41 43 1324 1326 O
Day 44 47 1327 1330 O
0 48 49 1331 1332 O
in 50 52 1333 1335 O
the 53 56 1336 1339 O
study 57 62 1340 1345 O
eye 63 66 1346 1349 O

Intravitreal 0 12 1350 1362 B-treatment
injections 13 23 1363 1373 I-treatment
( 24 25 1374 1375 O
including 25 34 1375 1384 O
but 35 38 1385 1388 O
not 39 42 1389 1392 O
limited 43 50 1393 1400 O
to 51 53 1401 1403 O
anti 54 58 1404 1408 B-treatment
- 58 59 1408 1409 I-treatment
vascular 59 67 1409 1417 I-treatment
endothelial 68 79 1418 1429 I-treatment
growth 80 86 1430 1436 I-treatment
factors 87 94 1437 1444 I-treatment
60 95 97 1445 1447 B-upper_bound
days 98 102 1448 1452 I-upper_bound
prior 103 108 1453 1458 I-upper_bound
to 109 111 1459 1461 O
the 112 115 1462 1465 O
baseline 116 124 1466 1474 O

Males 0 5 1475 1480 B-gender

Media 0 5 1481 1486 O
opacity 6 13 1487 1494 O
that 14 18 1495 1499 O
would 19 24 1500 1505 O
limit 25 30 1506 1511 O
clinical 31 39 1512 1520 O
visualization 40 53 1521 1534 O
, 53 54 1534 1535 O
intravenous 55 66 1536 1547 B-treatment
fluorescein 67 78 1548 1559 I-treatment
angiography 79 90 1560 1571 I-treatment
( 91 92 1572 1573 I-treatment
IVFA 92 96 1573 1577 I-treatment
) 96 97 1577 1578 I-treatment
, 97 98 1578 1579 O
or 99 101 1580 1582 O
OCT 102 105 1583 1586 B-treatment
evaluation 106 116 1587 1597 I-treatment
in 117 119 1598 1600 O
the 120 123 1601 1604 O
study 124 129 1605 1610 O
eye 130 133 1611 1614 O

Ocular 0 6 1615 1621 B-chronic_disease
or 7 9 1622 1624 I-chronic_disease
periocular 10 20 1625 1635 I-chronic_disease
infection 21 30 1636 1645 I-chronic_disease
in 31 33 1646 1648 O
either 34 40 1649 1655 O
eye 41 44 1656 1659 O

Participation 0 13 1660 1673 O
in 14 16 1674 1676 O
other 17 22 1677 1682 O
investigational 23 38 1683 1698 O
drug 39 43 1699 1703 O
or 44 46 1704 1706 O
device 47 53 1707 1713 O
clinical 54 62 1714 1722 O
trials 63 69 1723 1729 O
within 70 76 1730 1736 O
30 77 79 1737 1739 B-upper_bound
days 80 84 1740 1744 I-upper_bound
prior 85 90 1745 1750 I-upper_bound
to 91 93 1751 1753 O
Day 94 97 1754 1757 O
0 98 99 1758 1759 O
, 99 100 1759 1760 O
or 101 103 1761 1763 O
planning 104 112 1764 1772 O
to 113 115 1773 1775 O
participate 116 127 1776 1787 O
in 128 130 1788 1790 O
other 131 136 1791 1796 O
investigational 137 152 1797 1812 O
drug 153 157 1813 1817 O
or 158 160 1818 1820 O
device 161 167 1821 1827 O
clinical 168 176 1828 1836 O
trials 177 183 1837 1843 O
within 184 190 1844 1850 O
180 191 194 1851 1854 B-upper_bound
days 195 199 1855 1859 I-upper_bound
following 200 209 1860 1869 O
Day 210 213 1870 1873 O
0 214 215 1874 1875 O

Patients 0 8 1876 1884 O
with 9 13 1885 1889 O
bilateral 14 23 1890 1899 B-chronic_disease
uveitis 24 31 1900 1907 I-chronic_disease
who 32 35 1908 1911 O
are 36 39 1912 1915 O
receiving 40 49 1916 1925 O
systemic 50 58 1926 1934 B-treatment
immunosuppressive 59 76 1935 1952 I-treatment
therapy 77 84 1953 1960 I-treatment
( 85 86 1961 1962 O
e.g. 86 90 1962 1966 O
, 90 91 1966 1967 O
methotrexate 92 104 1968 1980 B-treatment
, 104 105 1980 1981 O
cyclosporine 106 118 1982 1994 B-treatment
, 118 119 1994 1995 O
cyclophosphamide 120 136 1996 2012 B-treatment
, 136 137 2012 2013 O
chlorambucil 138 150 2014 2026 B-treatment
, 150 151 2026 2027 O
mycophenolate 152 165 2028 2041 B-treatment
mofetil 166 173 2042 2049 B-treatment
, 173 174 2049 2050 O
tacrolimus 175 185 2051 2061 B-treatment
, 185 186 2061 2062 O
or 187 189 2063 2065 O
azathioprine 190 202 2066 2078 B-treatment
) 202 203 2078 2079 O
other 204 209 2080 2085 O
than 210 214 2086 2090 O
prednisone 215 225 2091 2101 B-treatment
or 226 228 2102 2104 O
other 229 234 2105 2110 O
corticosteroids 235 250 2111 2126 B-treatment
for 251 254 2127 2130 O
the 255 258 2131 2134 O
treatment 259 268 2135 2144 B-treatment
of 269 271 2145 2147 O
uveitis 272 279 2148 2155 O
and 280 283 2156 2159 O
the 284 287 2160 2163 O
uveitis 288 295 2164 2171 O
in 296 298 2172 2174 O
the 299 302 2175 2178 O
fellow 303 309 2179 2185 O
eye 310 313 2186 2189 O
, 313 314 2189 2190 O
in 315 317 2191 2193 O
the 318 321 2194 2197 O
opinion 322 329 2198 2205 O
of 330 332 2206 2208 O
the 333 336 2209 2212 O
Investigator 337 349 2213 2225 O
, 349 350 2225 2226 O
can 351 354 2227 2230 O
not 354 357 2230 2233 O
be 358 360 2234 2236 O
controlled 361 371 2237 2247 O
with 372 376 2248 2252 O
standard 377 385 2253 2261 B-treatment
local 386 391 2262 2267 I-treatment
therapies 392 401 2268 2277 I-treatment
alone 402 407 2278 2283 O

Posterior 0 9 2284 2293 B-treatment
subtenon 10 18 2294 2302 I-treatment
's 18 20 2302 2304 I-treatment
or 21 23 2305 2307 O
intravitreal 24 36 2308 2320 B-treatment
injection 37 46 2321 2330 I-treatment
of 47 49 2331 2333 O
steroids 50 58 2334 2342 B-treatment
90 59 61 2343 2345 B-upper_bound
days 62 66 2346 2350 I-upper_bound
prior 67 72 2351 2356 I-upper_bound
to 73 75 2357 2359 I-upper_bound
Baseline 76 84 2360 2368 I-upper_bound

Presence 0 8 2369 2377 O
of 9 11 2378 2380 O
any 12 15 2381 2384 O
form 16 20 2385 2389 O
of 21 23 2390 2392 O
ocular 24 30 2393 2399 B-cancer
malignancy 31 41 2400 2410 I-cancer
in 42 44 2411 2413 O
the 45 48 2414 2417 O
study 49 54 2418 2423 O
eye 55 58 2424 2427 O
, 58 59 2427 2428 O
including 60 69 2429 2438 O
choroidal 70 79 2439 2448 B-cancer
melanoma 80 88 2449 2457 I-cancer

Presence 0 8 2458 2466 O
of 9 11 2467 2469 O
known 12 17 2470 2475 O
active 18 24 2476 2482 O
or 25 27 2483 2485 O
inactive 28 36 2486 2494 O
toxoplasmosis 37 50 2495 2508 B-chronic_disease
in 51 53 2509 2511 O
either 54 60 2512 2518 O
eye 61 64 2519 2522 O

Pupillary 0 9 2523 2532 B-chronic_disease
dilation 10 18 2533 2541 I-chronic_disease
inadequate 19 29 2542 2552 O
for 30 33 2553 2556 O
quality 34 41 2557 2564 O
fundus 42 48 2565 2571 O
photography 49 60 2572 2583 O
in 61 63 2584 2586 O
the 64 67 2587 2590 O
study 68 73 2591 2596 O
eye 74 77 2597 2600 O

Sufficient 0 10 2601 2611 O
inflammation 11 23 2612 2624 O
to 24 26 2625 2627 O
require 27 34 2628 2635 O
systemic 35 43 2636 2644 B-treatment
treatment 44 53 2645 2654 I-treatment
and 54 57 2655 2658 O
, 57 58 2658 2659 O
based 59 64 2660 2665 O
on 65 67 2666 2668 O
the 68 71 2669 2672 O
Investigator 72 84 2673 2685 O
's 84 86 2685 2687 O
decision 87 95 2688 2696 O
, 95 96 2696 2697 O
warrants 97 105 2698 2706 O
intravitreal 106 118 2707 2719 B-treatment
treatment 119 128 2720 2729 I-treatment

are 0 3 2730 2733 O
receiving 4 13 2734 2743 O
no 14 16 2744 2746 O
treatment 17 26 2747 2756 B-treatment

at 0 2 2757 2759 O
least 3 8 2760 2765 O
1 9 10 2766 2767 B-lower_bound
systemic 11 19 2768 2776 B-treatment
immunosuppressant 20 37 2777 2794 I-treatment
other 38 43 2795 2800 O
than 44 48 2801 2805 O
corticosteroids 49 64 2806 2821 B-treatment

combination 0 11 2822 2833 O
of 12 14 2834 2836 O
prednisone 15 25 2837 2847 B-treatment
< 26 27 2848 2849 O
10 27 29 2849 2851 B-upper_bound
mg 30 32 2852 2854 I-upper_bound
/ 32 33 2854 2855 I-upper_bound
day 33 36 2855 2858 I-upper_bound
( 37 38 2859 2860 O
or 38 40 2860 2862 O
equivalent 41 51 2863 2873 O
dose 52 56 2874 2878 O
of 57 59 2879 2881 O
another 60 67 2882 2889 O
corticosteroid 68 82 2890 2904 B-treatment
) 82 83 2904 2905 O
and 84 87 2906 2909 O
other 88 93 2910 2915 O
systemic 94 102 2916 2924 B-treatment
immunosuppressant 103 120 2925 2942 I-treatment

combination 0 11 2943 2954 O
of 12 14 2955 2957 O
prednisone 15 25 2958 2968 B-clinical_variable
≥ 26 27 2969 2970 O
10 28 30 2971 2973 B-lower_bound
mg 31 33 2974 2976 I-lower_bound
/ 33 34 2976 2977 I-lower_bound
day 34 37 2977 2980 I-lower_bound
( 38 39 2981 2982 O
or 39 41 2982 2984 O
equivalent 42 52 2985 2995 O
dose 53 57 2996 3000 O
of 58 60 3001 3003 O
another 61 68 3004 3011 O
corticosteroid 69 83 3012 3026 B-treatment
) 83 84 3026 3027 O
and 85 88 3028 3031 O
other 89 94 3032 3037 O
systemic 95 103 3038 3046 B-treatment
immunosuppressant 104 121 3047 3064 I-treatment

females 0 7 3065 3072 B-gender

greater 0 7 3073 3080 O
than 8 12 3081 3085 O
or 13 15 3086 3088 O
equal 16 21 3089 3094 O
to 22 24 3095 3097 O
12 25 27 3098 3100 B-lower_bound
years 28 33 3101 3106 I-lower_bound
of 34 36 3107 3109 O
age 37 40 3110 3113 B-age

prednisone 0 10 3114 3124 B-treatment
< 11 12 3125 3126 O
10 12 14 3126 3128 B-upper_bound
mg 15 17 3129 3131 I-upper_bound
/ 17 18 3131 3132 I-upper_bound
day 18 21 3132 3135 I-upper_bound
( 22 23 3136 3137 O
or 23 25 3137 3139 O
equivalent 26 36 3140 3150 O
dose 37 41 3151 3155 O
of 42 44 3156 3158 O
another 45 52 3159 3166 O
corticosteroid 53 67 3167 3181 B-treatment
) 67 68 3181 3182 O

prednisone 0 10 3183 3193 B-treatment
≥ 11 12 3194 3195 O
10 13 15 3196 3198 B-lower_bound
mg 16 18 3199 3201 I-lower_bound
/ 18 19 3201 3202 I-lower_bound
day 19 22 3202 3205 I-lower_bound
( 23 24 3206 3207 O
or 24 26 3207 3209 O
equivalent 27 37 3210 3220 O
dose 38 42 3221 3225 O
of 43 45 3226 3228 O
another 46 53 3229 3236 O
corticosteroid 54 68 3237 3251 B-treatment
) 68 69 3251 3252 O

